TWI226927B - Herbal chip - Google Patents

Herbal chip Download PDF

Info

Publication number
TWI226927B
TWI226927B TW90113695A TW90113695A TWI226927B TW I226927 B TWI226927 B TW I226927B TW 90113695 A TW90113695 A TW 90113695A TW 90113695 A TW90113695 A TW 90113695A TW I226927 B TWI226927 B TW I226927B
Authority
TW
Taiwan
Prior art keywords
herbal
scope
patent application
item
plastic slide
Prior art date
Application number
TW90113695A
Other languages
Chinese (zh)
Inventor
Su-Jen Jang
Li-Wei Shiu
Jr-Ping Chen
Jeng-Wei Li
Original Assignee
Advanced Gene Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Gene Technology Corp filed Critical Advanced Gene Technology Corp
Priority to TW90113695A priority Critical patent/TWI226927B/en
Application granted granted Critical
Publication of TWI226927B publication Critical patent/TWI226927B/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present invention relates to an herbal chip comprising a plastic slide, a coating as a spacer on the plastic slide, and fractions or components obtained from herbs that are independently allocated in microarrays on the coating. The herbal chip is useful for screening for active ingredients contained in the herbs that have specific pharmacological or therapeutical functions.

Description

1226927 A7 經濟部智慧財產局員工消費合作社印製 B7五、發明說明(1 ) 技術領域 本發明關於在塑膠基質上以微陣列之方式配置草藥之 分級液或成份。該配置有草藥分級液或成份之塑膠基質係 用於充作平台以篩選草藥中具有特定藥理活性或治療功效 之活性成份。 發明背景 許多年來已知使用草藥或其萃取液或分級液以充作藥 物。例如,使用柳樹之樹皮以充作抗發熱劑和止痛劑已有 2〇0 0年之久’及自西元1 7世紀已使用秘魯金雞納( Cinchona)之樹皮萃取液以治療瘧疾。 然而’迄今僅發現數種具有特定藥理活性或治療功效 之草藥活性成份。例如、·於西元2 〇世紀中期確認水楊苔 (一種水楊醇葡糖苷)係柳樹之樹皮中具有抗發熱活性和 止痛活性之活性成份,及於西元1 8 2 0年確認奎寧係秘 魯金雞納之樹皮中具有治療瘧疾功效之活性成份。 自草藥中發現具有特定藥理活性或治療功效之活性成 份係相當費時且耗費人力的。例如,經自全世界收集超過 3 5 0 0 0個植物屬種並篩選其超過1 1 〇 〇 〇 〇個樣品 後’頃自北美紅豆杉Taxus brevifolia之樹皮中分離出抗腫 瘤藥物—紫杉醇(taxol )。通常,找出存在於草藥中之活 性成份的一般模式係確認該草藥於人體中之功效,並藉由 利用各種不同之物理和化學方法以分離草藥之活性分級液 ,且隨後分離及純化其中之活性成份。分離並純化出草藥 7紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱)_ 4 - (請先閱讀背面之注意事項再填寫本頁)1226927 A7 Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs B7 V. Description of the Invention (1) Technical Field The present invention relates to the arrangement of herbal graded liquids or ingredients in a microarray on a plastic substrate. The plastic matrix with herbal grade liquid or ingredients is used as a platform for screening active ingredients with specific pharmacological or therapeutic effects in herbs. Background of the invention The use of herbs or their extracts or fractions for filling medicines has been known for many years. For example, the bark of willow has been used as an antipyretic and analgesic for 2000 years' and bark extract of Cinchona, Peru has been used since the 17th century to treat malaria. However, to date, only a few herbal active ingredients have been found to have specific pharmacological or therapeutic effects. For example, in the mid-20th century AD, salicypid (a salicyl alcohol glucoside) was identified as an active ingredient with antipyretic and analgesic activity in the bark of willows, and quinine was identified in Peru in 1802 Cinchona bark has active ingredients in the treatment of malaria. The discovery of active ingredients with specific pharmacological or therapeutic effects from herbs is time consuming and labor intensive. For example, after collecting more than 35,000 plant genera from all over the world and screening more than 110,000 samples, the antitumor drug taxol (taxol) was isolated from the bark of Taxus brevifolia. ). Generally, the general pattern of finding the active ingredients present in herbal medicines is to confirm the efficacy of the herbal medicines in the human body, and to use various physical and chemical methods to separate the active fractions of herbal medicines, and then isolate and purify them. Active ingredient. Isolate and purify herbs 7 paper sizes are applicable to Chinese National Standard (CNS) A4 specifications (210 X 297 public love) _ 4-(Please read the precautions on the back before filling this page)

裝 ϋ n n .f , n n -ϋ 1 an I n . 1226927 A7 B7 五、發明說明(2 ) 中所含有之活性成份並無一定之通則。雖然基於藥理學, 細胞生物學及分子生物學之發展已於分子或基因階層上對 致病原因之了解有顯著的進展,且已發展出標的物篩選( shotgun screening )草藥之萃取液之技術以期能直接命中得 到存在於草藥中所欲之活性成份,但是分離並純化出草藥 中之活性成份仍然是耗費人力及嘗試錯誤之工作,且其進 展仍然緩慢。 此技藝已對能發展出一種新穎之方法及/或工具以自 草藥或其萃取液或分級液中迅速篩選出具有特定之藥理活 性或治療功效的活性成份存有顯著的需求。 固定大生物性分子於固體基質(例如,耐隆膜)上之 技術已使用於此技藝中,例如西方吸漬法係用於固定肽或 蛋白質,南方吸漬法係用於固定D N A片段,及北方吸漬 法係用於固定R N A片段,並令固定化之分子與標記探針 作用或反應,且隨後顯影所生成之經探針標記之分子。例 如,連接酶免疫吸附分析法(E L I S A )涉及固定化大 生物分子於基質上,令該固定化之分子與標記物作用或反 應,及隨後著色並顯影所生成之標記分子。該E L I S A 可於慣用之9 6孔槽微盤上進行。 近來,高密度欄格技術(High-density gndding technology )已使用於此技藝中以用於偵測生物性樣品(例 如,D N A或蛋白質)中是否存有所欲之標的物,其中樣 品係以預定之排列方式固定於固體基質(例如,玻璃載片 )上,且利用標記探針進行雜交,隨後進行沖洗及顯影。 丨裝 (請先閱讀背面之注意事項再填寫本頁)Loading n n .f, n n -ϋ 1 an I n. 1226927 A7 B7 5. There are no general rules for the active ingredients contained in the description of the invention (2). Although based on pharmacology, the development of cell biology and molecular biology has made significant progress in understanding the cause of disease at the molecular or genetic level, and the technology of targetgun screening of herbal extracts has been developed with a view to It can directly hit to get the active ingredients that are in the herbal medicine, but isolating and purifying the active ingredients in the herbal medicine is still a labor-intensive and trial-and-error job, and its progress is still slow. This technology has a significant need to develop a novel method and / or tool for the rapid screening of active ingredients with specific pharmacological activity or therapeutic efficacy from herbs or their extracts or fractions. Techniques for immobilizing large biomolecules on a solid substrate (eg, nylon membrane) have been used in this technique, such as western blotting systems for immobilizing peptides or proteins, southern blotting systems for immobilizing DNA fragments, and The northern blotting method is used to immobilize RNA fragments and cause the immobilized molecules to react or react with the labeled probes, and then develop the resulting probe-labeled molecules. For example, the ligase immunosorbent assay (ELISA) involves immobilizing large biomolecules on a substrate, allowing the immobilized molecules to react or react with a marker, and subsequently coloring and developing the resulting labeled molecules. The E L I S A can be performed on a conventional 96-well microplate. Recently, High-density gndding technology has been used in this technology to detect whether there is a desired target in a biological sample (eg, DNA or protein), where the sample is pre-determined The arrangement is fixed on a solid substrate (eg, a glass slide) and hybridized with a labeled probe, followed by washing and development.丨 Loading (Please read the precautions on the back before filling this page)

i_l n n .1 J 、· n n n ammmm f n an - 經濟部智慧財產局員工消費合作社印制衣 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -5- 1226927 Α7 Β7 經濟部智慧財產局員工消費合作社印制衣 i、發明說明(3 ) 於應用該高密度欄格技術時,該生物性樣品係呈均一相之 已知DNA或蛋白質庫,且該標記探針係呈不均相之未知 或未經鑑定之物質。該高密度欄格技術之優點係在於可將 極少量體積之樣品固定於基質表面之小欄格面積上,及可 同時操作數千個樣品。進一步,可使用電腦控制之3度空 間自動機械裝置及單一管尖組件(即微陣列器)以於基質 之表面上產生高密度欄格排列之生物性樣品。 然而,迄今該高密度欄格技術僅用於分析大分子,諸 如蛋白質和核酸,其中固定於固體基質(例如,玻璃載片 )之表面上的樣品係呈均一相。此技藝並未教示或建議可 將含有大生物活性分子(諸如,蛋白質或核酸)或小生物 活性分子(諸如,二級代謝物)之不均相樣品固定於固體 基質(例如,塑膠載片y之表面上。此技藝亦未教示或建 議可將草藥或其萃取液或分級液之均一相或不均相樣品固 定於固體基質(例如,塑膠載片)之表面上,特別是該樣 品係以微陣列之方式排列。進一步,此技藝並未教示或建 議藉由應用該高密度欄格技術,令配置於固體基質(例如 ’塑膠載片)之表面上的均一相或不均相未知樣品與均一 相或不均相之已知標記探針作用或反應,可進行草藥中具 生物活性之分子的高效篩選(high throughput screening ) ο 據此,本發明揭示一種利用均一相或不均相之已知標 記探針以篩選草藥中之活性成份的新穎平台,其包含固定 化於固體基質(例如,塑膠載片)上之草藥均一相或不均 (請先閱讀背面之注意事項再填寫本頁)i_l nn .1 J 、 · nnn ammmm fn an-The printed paper size of the employee's consumer cooperative of the Intellectual Property Bureau of the Ministry of Economy applies the Chinese National Standard (CNS) A4 (210 X 297 mm) -5- 1226927 Α7 Β7 Ministry of Economy Intellectual Property Bureau employee clothing cooperative printed clothes i. Description of invention (3) When the high-density column technology is applied, the biological sample is a homogeneous known DNA or protein library, and the labeled probe is not Homogeneous unknown or unidentified substance. The advantages of this high-density grid technology are that a very small volume of sample can be fixed to a small grid area on the surface of the substrate, and thousands of samples can be operated simultaneously. Further, a computer controlled 3-degree space robotic device and a single tip assembly (ie, a microarrayer) can be used to generate biological samples in a high-density array on the surface of the substrate. However, to date this high-density column technique has been used only for the analysis of large molecules, such as proteins and nucleic acids, where the sample immobilized on the surface of a solid substrate (for example, a glass slide) is homogeneous. This technique does not teach or suggest that heterogeneous samples containing large bioactive molecules (such as proteins or nucleic acids) or small bioactive molecules (such as secondary metabolites) can be immobilized on a solid substrate (eg, plastic slides) This technique also does not teach or suggest that homogeneous or heterogeneous samples of herbs or their extracts or fractions can be fixed on the surface of a solid substrate (eg, a plastic slide), especially if the sample is Microarrays are arranged. Further, this technique does not teach or suggest that by applying the high-density grid technology, the homogeneous or heterogeneous unknown sample disposed on the surface of a solid substrate (such as a 'plastic slide') and Homogeneous or heterogeneous known labeled probe action or reaction can be used for high throughput screening of biologically active molecules in herbs. Based on this, the present invention discloses a method using homogeneous or heterogeneous Novel platform for labeling probes to screen active ingredients in herbal medicines, including a homogeneous phase of herbal medicines immobilized on a solid substrate (eg, plastic slide) Uneven (Please read the back of the precautions to fill out this page)

裝 ----訂-------- 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -6- 1226927 A7 B7 五、發明說明(4 ) 相分級液或成份。 發明簡沭 本發明揭示一種新穎之平台(稱爲草藥晶片),其包 含塑膠載片,於該塑膠載片上充作間隔子之塗層,及以微 陣列方式各別配置於該塗層上之草藥分級液或成份。本發 明之草藥晶片係用於篩選草藥中具有特定藥理活性或治療 功效之活性成份。 本發明亦揭示一種用於產製該草藥晶片之方法。 再者,本發明揭示一種利用該草藥晶片以篩選草藥所 含之活性成份的方法。 圖式簡單說明 、 圖1說明用於製造本發明之草藥晶片的塑膠載片之透 視圖。 圖2 A例示本發明之草藥晶片的實例,其中樣品係以 6 X 1 0距陣之方式欄格於圖1所示之塑膠載片上。 圖2 B顯示於利用標記探針進行雜交反應前,圖2 A 所示之草藥晶片上的欄格樣品所顯現之內生性螢光。 圖2 C顯示於利用經C y 3標記之T N F — a R (腫 瘤壞死因子α受體)及經C y 5標記之鏈球菌抗生物素蛋 白進行雜交反應後,圖2 A所示之草藥晶片上的欄格樣品 所顯現之螢光影像。 圖3顯示2個顯現綠色螢光(C y 3 )訊號之選擇樣 (請先閱讀背面之注意事項再填寫本頁) 裝 gmm§ I ϋ flu J V 馨-i_i n n n n I— n · 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公釐‘) -7- 1226927 Α7 Β7 五、發明說明(5 ) 品(草藥C之分級液4和5 ’其分別對應於圖2 A所示之 草藥晶片上B 7和B 8 ’及B 9和B 1 〇位置上之配置點 )於競爭性抑制T N F — a / T N F - a R結合上之功效 〇 發明詳述 本發明揭示一種新穎之平台(稱爲草藥晶片),其係 用於以標的物導向之方式標的物篩選草藥所含有之活性成 份以達到高效之結果。本發明之草藥晶片包含塑膠載片, 於該塑膠載片上充作間隔子之塗層,及以微陣列方式各別 配置或固定於該塗層上之草藥分級液或成份。 於本發明之草藥晶片中,每1個以微陣列方式點配置 乂 之草藥分級液或成份本_上係爲得自於草藥之未經界定, 均一相或不均相,部份純化之混合物。可藉由應用儀器( 例如’ Η P L C )以分級分離草藥之萃取液以得到該分級 液或成份。該草藥晶片上每一個配置點可包含草藥之二級 代謝物。 本發明之草藥晶片係使用塑膠載片以取代慣用之玻璃 載片。該塑膠載片之材料可爲同聚物或共聚物,其係由1 種或多種單體所製備,該單體係選自乙烯,鹵乙烯,丙烯 ,鹵丙烯,丙烯酸酯,甲基丙烯酸酯,丁二烯,丙烯腈, 原冰片烯或苯乙烯,其中苯乙烯之聚合物係適宜的。該塑 膠載片之材料亦包括聚碳酸酯。該塑膠載片之大小係相當 於微陣列器或雷射掃描器所慣用之載片大小。本發明之草 (請先閱讀背面之注意事項再填寫本頁) | ------丨丨訂*----丨丨丨 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐‘) -8- 1226927 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(6 ) 藥晶片使用塑膠載片之優點係在於可使用各種不同之化學 藥劑以處理塑膠載片之表面,使得不僅是大分子(諸如蛋 白質和D N A ),亦包括小分子(諸如草藥之代謝物)可 固定於塑膠載片之表面上。此優點若對照慣用之玻璃載片 僅能用於固定大分子(諸如蛋白質和DNA)之事實尤顯 得重要。再者’塑膠載片可易於模製成所欲之形狀,且亦 具有成本低之優異性。於本發明之較佳體系中,塑膠載片 係經模製以具有2個凹槽(如圖1所示),其中得自於草 藥之分級液或成份的樣品可欄格化配置於該凹槽之表面上 ,且隨後可載入含有探針之溶液至該凹槽上以進行雜交反 應。該2個凹槽之深度可爲相同或不同,且係介於低於〇 .〇3mm至高達0 · 5mm之間。進一步,如示於圖1 ,每1個凹槽之相對2 -可分別模製欄桿以用於支撐玻璃 蓋,其中該玻璃蓋係用於防止蒸發或損失該載入至該凹槽 上之含有探針之溶液。 於本發明之草藥晶片中,利用多官能性醛及隨後所浸 沒於提供N Η 2基團之先驅物溶液中以先前處理該塑膠載片 ,使得所生成之塑膠載片於其表面上含有具活性之胺基。 該提供Ν Η 2基團之先驅物可爲有機物或無機物,且可選自 Ν Η 4〇Η,一級胺,二級胺或叔胺,其中該一級胺,二級 胺及叔胺之脂族及/或芳族部份可用於充作額外之間隔子 。於該提供Ν Η 2基團之先驅物中,直接提供自由Ν Η 2基 團之ΝΗ4〇Η係適宜的。 於本發明之草藥晶片中,該塑膠載片上之塗層係由多 (請先閱讀背面之注意事項再填寫本頁) 裝Binding ---- Order -------- This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) -6- 1226927 A7 B7 V. Description of the invention (4) Phase grading solution or Ingredients. SUMMARY OF THE INVENTION The present invention discloses a novel platform (called a herbal wafer), which includes a plastic slide, a coating of a spacer is filled on the plastic slide, and micro-arrays are separately arranged on the coating. Herbal grading solution or ingredients. The herbal wafer of the present invention is used for screening active ingredients with specific pharmacological activity or therapeutic effect in herbal medicine. The invention also discloses a method for producing the herbal medicine wafer. Furthermore, the present invention discloses a method for using the herbal medicine wafer to screen active ingredients contained in herbal medicine. Brief description of the drawings, Fig. 1 illustrates a perspective view of a plastic slide used to manufacture the herbal wafer of the present invention. FIG. 2A illustrates an example of the herbal medicine wafer of the present invention, in which the sample is gridded on the plastic slide shown in FIG. 1 with a 6 × 10 matrix. FIG. 2B shows the endogenous fluorescence of the column sample on the herbal medicine wafer shown in FIG. 2A before the hybridization reaction using the labeled probe. Figure 2C shows the herbal wafer shown in Figure 2A after hybridization using Cy 3 labeled TNF — a R (tumor necrosis factor alpha receptor) and Cy 5 labeled streptococcal avidin. The fluorescent image of the sample displayed in the upper column. Figure 3 shows two selections of green fluorescent (C y 3) signals (please read the precautions on the back before filling this page). Gmm§ I ϋ flu JV Xin-i_i nnnn I— n The paper size printed by the Bureau ’s Consumer Cooperatives applies the Chinese National Standard (CNS) A4 specification (210 x 297 mm ') -7- 1226927 Α7 Β7 V. Description of the invention (5) Product (Classification liquid 4 and 5 of Herbal C) It corresponds to the disposition points at positions B 7 and B 8 ′ and B 9 and B 10 on the herbal medicine wafer shown in FIG. 2A) for the competitive inhibition of TNF — a / TNF-a R binding. DETAILED DESCRIPTION The present invention discloses a novel platform (called a herbal chip), which is used to screen the active ingredients contained in herbs in a target-oriented manner to achieve high-efficiency results. The herbal medicine wafer of the present invention comprises a plastic slide, which is filled with a coating of a spacer on the plastic slide, and a herbal grading solution or component arranged or fixed on the coating in a microarray manner. In the herbal medicine wafer of the present invention, each herbal medicine graded solution or component is arranged in a microarray manner. The above is an undefined, homogeneous or heterogeneous, partially purified mixture derived from herbal medicine. . The graded solution or composition can be obtained by fractionating the extract of the herbal medicine by applying an instrument (for example, 'ΗPLC). Each configuration point on the herbal wafer may contain secondary metabolites of the herbal. The herbal wafer of the present invention uses a plastic slide instead of a conventional glass slide. The material of the plastic slide can be a homopolymer or a copolymer, which is prepared from one or more monomers, and the single system is selected from ethylene, vinyl halide, propylene, halopropylene, acrylate, methacrylate , Butadiene, acrylonitrile, orbornene or styrene, of which styrene polymers are suitable. The plastic slide also includes polycarbonate. The size of the plastic slide is equivalent to that of a microarrayer or a laser scanner. The grass of the invention (please read the notes on the back before filling out this page) | ------ 丨 丨 Order * ---- 丨 丨 丨 Printed by the Consumers ’Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, the paper size is suitable for China National Standard (CNS) A4 specification (210 X 297 mm ') -8- 1226927 A7 B7 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 5. Description of the invention (6) The advantage of using plastic slides for medicine chips is that they can be used Various chemicals are used to treat the surface of plastic slides, so that not only large molecules (such as proteins and DNA), but also small molecules (such as metabolites of herbs) can be fixed on the surface of plastic slides. This advantage is particularly important in contrast to the fact that conventional glass slides can only be used to immobilize large molecules such as proteins and DNA. Furthermore, the plastic slide can be easily molded into a desired shape, and it also has the advantage of low cost. In the preferred system of the present invention, the plastic slide is molded to have 2 grooves (as shown in FIG. 1), and the sample obtained from the herbal grade liquid or composition can be arranged in the groove. The surface of the groove, and then a solution containing a probe can be loaded onto the groove for a hybridization reaction. The depth of the two grooves may be the same or different, and is between less than 0.03 mm and as high as 0.5 mm. Further, as shown in FIG. 1, the relative 2 of each groove can be separately molded to support a glass cover, wherein the glass cover is used to prevent evaporation or loss of the contents loaded on the groove. Probe solution. In the herbal medicine wafer of the present invention, a polyfunctional aldehyde and a subsequent immersion in a precursor solution providing N Η 2 groups are used to previously treat the plastic slide, so that the generated plastic slide contains a surface with Reactive amine group. The precursor for providing the N Η 2 group may be organic or inorganic, and may be selected from the group consisting of Η Η 40Η, a primary amine, a secondary amine, or a tertiary amine, wherein the primary amine, the secondary amine, and the tertiary amine are aliphatic. And / or the aromatic portion can be used as an additional spacer. In the precursor of providing the N Η 2 group, it is suitable to directly provide the Η Η Η of the free Η 2 group. In the herbal wafer of the present invention, the coating on the plastic slide is made by (please read the precautions on the back before filling this page).

讎 — — I — — II # 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐‘) _ 9 - 經濟部智慧財產局員工消費合作社印製 1226927 A7 B7 五、發明說明(7 ) 官能性分子(例如,多官能性環氧化物)所構成,其係充 作間隔子。該多官能性環氧化物之作用係連接草藥所含之 成份至該經先期處理之塑膠載片上。該多官能性環氧化物 之一端的活性環氧基係與該經先期處理之塑膠載片的表面 上之胺基反應,而該多官能性環氧化物之另一端的活性環 氧基係吸附或與草藥所含之成份反應。詳言之,草藥成份 中含有自由經基,氫硫基及/或胺基之分子能與該多官會g 性環氧化物之另一端的活性環氧基形成1個共價鍵,因而 該分子隨後能連接至該塑膠載片上。該多官能性環氧化物 適宜地係含有6至2 4個碳原子長之化學鏈,使得草藥所 含之成份不會直接地結合或吸附至該經先期處理之塑膠載 片上。於本發明之草藥晶片中,每1個配置點對經塗覆之 塑膠載片之結合係牢固的,甚至經嚴厲之脫離沖洗後亦然 。於本發明中,不僅是大分子(諸如蛋白質和DNA), 亦包括小分子(諸如草藥之代謝物)皆可以均一相或不均 相之方式固定於該經塗覆之塑膠載片的表面上。 製備本發明之草藥晶片包含下列之步驟:製備塑膠載 片(適宜地含有凹槽),利用多官能性醛及隨後浸沒於提 供N Η 2基團之先驅物溶液(適宜地係N Η 4〇Η溶液)中 以先期處理該塑膠載片,利用多官能性分子(適宜地係多 官能性環氧化物)以塗覆該經先期處理之塑膠載片之表面 ,及於該經塗覆之塑膠載片之表面上,藉由應用高密度欄 格技術,利用微陣列器以微陣列之方式於欄格面積上點配 置且固定化大量之樣品,其中每1個樣品點含有呈均一相 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱) .雠 — — I — — II # This paper size applies to China National Standard (CNS) A4 (210 X 297 mm ') _ 9-Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs 1226927 A7 B7 V. Description of the invention (7 ) Functional molecules (for example, polyfunctional epoxides) that act as spacers. The function of the multifunctional epoxide is to connect the ingredients contained in the herbal medicine to the pre-treated plastic slide. An active epoxy group at one end of the multifunctional epoxy is reacted with an amine group on the surface of the pre-treated plastic slide, and an active epoxy group at the other end of the multifunctional epoxy is adsorbed. Or react with the ingredients contained in herbs. In detail, molecules containing free radicals, hydrogen sulfide groups and / or amine groups in the herbal ingredients can form a covalent bond with the active epoxy group at the other end of the polyfunctional g-epoxide. Molecules can then be attached to the plastic slide. The polyfunctional epoxide suitably contains a chemical chain with a length of 6 to 24 carbon atoms, so that the ingredients contained in the herbal medicine will not be directly bound or adsorbed to the pre-treated plastic slide. In the herbal medicine wafer of the present invention, the bonding of each coated point to the coated plastic slide is firm, even after severe disengagement. In the present invention, not only macromolecules (such as proteins and DNA), but also small molecules (such as metabolites of herbs) can be fixed on the surface of the coated plastic slide in a homogeneous or heterogeneous manner. . The preparation of the herbal wafer of the present invention comprises the following steps: preparing a plastic slide (with grooves as appropriate), using a polyfunctional aldehyde and subsequently immersing in a precursor solution providing N Η 2 groups (suitably N Η 4) Η solution) to pre-treat the plastic slide, use multifunctional molecules (suitably polyfunctional epoxide) to coat the surface of the pre-treated plastic slide, and apply the plastic On the surface of the slide, by applying high-density grid technology, a microarray device is used to arrange and fix a large number of samples on the grid area in a microarray manner. Each sample point contains a uniform paper size. Applicable to China National Standard (CNS) A4 specification (210 X 297 public love).

1226927 經濟部智慧財產局員工消費合作社印製 Α7 Β7 五、發明說明(8 ) 或不均相之草藥分級液或成份。於製備本發明之草藥晶片 中,可使用整合性微小化技術(integrating miniaturization technology )以增加該經塗覆之塑膠載片上欄格樣品之密度 〇 本發明亦揭示一種利用該草藥晶片藉由標的物導向之 方式以篩選草藥所含之活性成份的方法,其包含下列之步 驟:將含有標記探針之溶液載入該草藥晶片(例如,該草 藥晶片之凹槽)上以進行雜交反應(其中可藉由利用玻璃 蓋以蓋住每一個凹槽以防止該含有標記探針之溶液的蒸發 ),及藉由儀器(例如,雷射掃描器)以顯像並鑑識出能 與該標記探針結合或反應之配置點。該連接探針之標記物 可爲染料或放射性物質。 本發明所使用之探針係基於已界定之分子機轉而呈均 一相或不均相之已知標的物,其可爲,例如,拮抗諸如選 擇之細胞,受體,酶或蛋白質類的小分子化合物,競爭性 配體,或抗體。於本發明之較佳體系中,係使用經C y 3 標記之腫瘤壤死因子α受體(TNF — aR)和經Cy 5 標記之鏈球菌抗生物素蛋白(strepavidin )充作探針以進 行雜交反應。因此,例如,若觀察到顯示該草藥晶片之配 置點中的成份與經標記之T N F — a R結合之訊號,其顯 示該配置點之成份中存有至少1種候選化合物,其具有類 似於抗T N F - a R抗體之生物活性。該等候選化合物可 用於充作拮抗劑以降低發炎反應,因而可用於治療自體% 疫疾病,諸如類風濕性關節炎。 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱‘) -11 - (請先閱讀背面之注意事項再填寫本頁) --------訂------I I · 1226927 經濟部智慧財產局員工消費合作社印製 A7 B7 五、發明說明(9 ) 本發明之草藥晶片可同時處理並檢測數千個樣品,因 此能顯著地增加標的物導向地篩選草藥中生物活性成份之 結果及效率。藉由使用本發明之草藥晶片,能迅速地檢測 ,分離並鑑定出任何存在於草藥中具有潛在藥理活性或治 療功效之成份。 本發明係以下述之實施例加以進一步之闡釋和說明, 但須明瞭的是本發明之範圍並不以下述之實施例爲限。 實施例 先前_處理塑膠載片及製備經塗覆之塑膠載片 利用苯乙烯之聚合物製備如圖1所示之模製塑膠載片 ’其含有2個凹槽。該模製塑膠載片之大小係相當於微陣 列器或雷射掃描器所使用之慣用玻璃載片,其中該凹槽之 深度係〇·〇5 m m。 首先,於室溫下令該模製塑膠載片浸沒於〇 . 4%戊 二醛溶液(p Η 5 ♦ 0 )中達4小時,隨後經水沖洗並於 6〇°C下浸漬於3Μ NH4〇H (pHl 1 · 〇)溶液中 達4小時。於3 7 °C下,利用1 0 〇 m Μ 1 ,4 — 丁二 醇一縮水甘油醚(pH 1 1 · 〇)隔夜處理所生成之塑膠 載片。最終,利用0 · 1 Μ N a H C〇3溶液( Ρ Η 8 · 〇 )沖洗該塑膠載片,並令其乾燥。 1甩微陣列方式載入樣品至經塗覆之塑膠載片上 利用微陣列器 BioGrid (購自 BioRobotic,Cambridge 本紙張尺度適用中國國家標準(CNS)A4規格(210 x 297公楚·) -12- (請先閱讀背面之注意事項再填寫本頁) 「裳--------訂---- # 1226927 A7 B7 五、發明說明(10 ) u κ )點配置樣品至該上述經塗覆之塑膠載片上。首先,令 樣品溶解並懸浮於9 6孔槽微盤上。利用4 一針(〇 · 2 〆m )管件連續地將樣品自該9 6孔槽微盤載入至該經塗 覆之塑膠載片的凹槽表面上,其中圖2 A所示之草藥樣品 係說明如下:草藥A和B之分級液係得自於蒲公英( Taraxacum mongoUcum )之不同分級液,草藥G係蒲公英之 粗萃取液,草藥F係涼喉(Hedyotis diffuse )之粗萃取液 ’草藥C之分級液1至9係得自於涼喉之不同且部份純化 之分級液,草藥D係忍冬( Lonicera japonica )之粗萃取液 ’草樂E係紅花(Carthamus tinctorius )之粗萃取液,草 藥J係一種得自於紅花之純化成份,草藥Η係連翹( Forsythia suspensa )之粗萃取液,及草藥I係芍藥(1226927 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs Α7 Β7 V. Description of invention (8) or heterogeneous herbal grading solution or ingredients. In the preparation of the herbal wafer of the present invention, integrating miniaturization technology can be used to increase the density of the grid sample on the coated plastic slide. The present invention also discloses a method for using the herbal wafer to pass the target A method for screening active ingredients contained in a herbal medicine in a guided manner, comprising the steps of: loading a solution containing a labeled probe onto the herbal wafer (eg, a groove of the herbal wafer) for hybridization reaction (wherein (By using a glass cover to cover each groove to prevent evaporation of the solution containing the labeled probe), and by means of an instrument (for example, a laser scanner) to visualize and identify that it can bind to the labeled probe Or reaction configuration points. The label of the connection probe may be a dye or a radioactive substance. The probes used in the present invention are based on known targets that are transformed into homogeneous or heterogeneous molecules based on a defined molecular mechanism, which may be, for example, antagonists such as selected cells, receptors, enzymes or proteins. Molecular compounds, competitive ligands, or antibodies. In the preferred system of the present invention, Cy 3 labeled tumor soil death factor alpha receptor (TNF — aR) and Cy 5 labeled streptococcal avidin (strepavidin) are used as probes to carry out Hybridization reaction. Therefore, for example, if a signal showing the combination of the component in the configuration point of the herbal wafer and the labeled TNF-αR is observed, it shows that there is at least one candidate compound in the component of the configuration point, which has a similar resistance to Biological activity of TNF-a R antibody. These candidate compounds can be used as antagonists to reduce the inflammatory response and therefore can be used to treat autoimmune diseases such as rheumatoid arthritis. This paper size applies to China National Standard (CNS) A4 specification (210 X 297 public love ') -11-(Please read the precautions on the back before filling this page) -------- Order ----- -II · 1226927 Printed by A7 B7, Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs 5. Description of Invention (9) The herbal wafer of the present invention can process and detect thousands of samples at the same time, so it can significantly increase the target-oriented screening of herbal medicines. Results and efficiency of biologically active ingredients. By using the herbal medicine wafer of the present invention, it is possible to quickly detect, isolate and identify any ingredient present in the herbal medicine with potential pharmacological activity or therapeutic effect. The present invention is further explained and illustrated by the following examples, but it must be understood that the scope of the present invention is not limited to the following examples. EXAMPLES Previous_Processing of plastic slides and preparation of coated plastic slides A molded plastic slide as shown in Figure 1 was prepared using a polymer of styrene, which contains 2 grooves. The size of the molded plastic slide is equivalent to that of a conventional glass slide used in a micro-array or laser scanner, wherein the depth of the groove is 0.05 mm. First, the molded plastic slide was immersed in a 0.4% glutaraldehyde solution (p Η 5 ♦ 0) at room temperature for 4 hours, and then rinsed with water and immersed in 3M NH4 at 60 ° C. H (pH l 1.0) for 4 hours. The resulting plastic slide was treated overnight at 37 ° C with 100 m Μ 1,4-butanediol-glycidyl ether (pH 1 1 · 〇). Finally, the plastic slide was rinsed with a 0.1 M NaHCO3 solution (pH 8.0) and allowed to dry. 1 Load the sample onto the coated plastic slide by using the microarray method and use the microarrayer BioGrid (purchased from BioRobotic, Cambridge). The paper size is in accordance with China National Standard (CNS) A4 (210 x 297). -12- (Please read the notes on the back before filling this page) "Shang -------- Order ---- # 1226927 A7 B7 V. Description of the invention (10) u κ) Place the sample to the above-mentioned coating Cover the plastic slide. First, the sample is dissolved and suspended on the 96-well trough microplate. The sample is continuously loaded from the 96-well trough microplate to the 96-well trough microplate using a 4-pin (0 · 2 〆m) tube. On the surface of the groove of the coated plastic slide, the herbal sample shown in Figure 2A is described as follows: The graded liquids of herbs A and B are obtained from different graded liquids of taraxacum mongoUcum. Crude extract of dandelion, crude extract of Herbal F series Hedyotis diffuse 'Grass Herbal C grades 1 to 9 are different and partially purified grades derived from cold throat, Herbal D is Lonicera japonica) crude extract 'Carthamus tinctorius' Liquid extract, Herbal medicine J is a purified ingredient obtained from safflower, crude extract of Herba Forsythia Forsythia (Forsythia suspensa), and Herbal I-type Paeonia (

XX

Paeonia lactiflora )之粗’萃取液。該塑膠載片之凹槽表面上 的配置點經乾燥後,於3 7 °C下利用1 Μ T r i s溶液 (ρ Η 8 · 0 )浸沒處理該塑膠載片2小時。利用雷射掃 描器(Ax〇n,USA )顯影所生成之塑膠載片以確定所有樣 品皆吸附於該塑膠載片上(參閱圖2 B )。 雜交反應及訊號側測 利用經C y 3標記之腫瘤壞死因子α受體(T N F — α R )和經C y 5標記之鏈球菌抗生物素蛋白(strep a vi din )充作探針以進行雜交反應。於載入含有該2種標記探針 之雜交溶液(1 〇 0 β 1 τ B S Τ緩衝液,其含有5 0 mM Tris,pH7.3,〇.15M NaCl, i紙張尺度中賴家標準(CNS)A4規格(210 X 297公釐).13. 「裝 (請先閱讀背面之注意事項#1填寫本頁) 訂 經濟部智慧財產局員工消費合作社印製 1226927 A7 B7 五、發明說明(11 ) 及〇.〇2% Tween 2〇)前,利用2個玻璃蓋 片分別蓋住該塑膠載片上之2個凹槽。令該塑膠載片於室 溫下靜置4小時,隨後以T B S T緩衝液沖洗3次及以水 沖洗3次。最終,令該塑膠載片於3 7 °C下乾燥。利用雷 射掃描器(Axon,USA )顯影該塑膠載片。該顯影結果係示 於圖2 C。 回收圖2 C顯影上顯現抑制T N F — a / T N F — α R結合之綠色螢光配置點。對應於該綠色螢光配置點之草 藥分級液係含有能夠與T N F - a R結合之活性成份。 顯示正向綠色螢光訊號之樣品的生物活性分析 爲證實上述所收集之分級液於抑制T N F - α / 丁 Ν X F — a R結合上之生_活性,進行文獻Mancini et al., Biochemical Pharmacology 58:851-859,1999 所描述之分析方 法,其中已知成份「蘇拉明」(S u r a m i η )係充作正向對照 組,並測試顯現綠色螢光之2個樣品(草藥C之分級液4 和5 ,其對應於圖2 Α草藥晶片上Β 7和Β 8 ,及Β 9和 B 1 0位置上之配置點)*。該測試結果係示於圖3。 「裝 (請先閱讀背面之注意事項再填寫本頁)Paeonia lactiflora). After the placement points on the groove surface of the plastic slide were dried, the plastic slide was immersed in a 1 M T r s solution (ρ Η 8 · 0) at 37 ° C for 2 hours. A laser scanner (Axon, USA) was used to develop the generated plastic slide to confirm that all samples were adsorbed on the plastic slide (see FIG. 2B). The hybridization reaction and signal side measurement were performed using Cy 3 labeled tumor necrosis factor alpha receptor (TNF — α R) and Cy 5 labeled streptococcal avidin (strep a vi din) as probes. Hybridization reaction. In a hybridization solution (100 β 1 τ BS Τ buffer containing the two kinds of labeled probes, which contains 50 mM Tris, pH 7.3, 0.15 M NaCl, i paper standard (CNS) ) A4 size (210 X 297 mm). 13. "Installation (please read the precautions on the back # 1 to fill out this page). Order printed by the Intellectual Property Bureau Employee Consumer Cooperative of the Ministry of Economic Affairs. 1226927 A7 B7 V. Invention Description (11) And 0.02% Tween 2〇), two glass coverslips were used to cover the two grooves on the plastic slide. The plastic slide was allowed to stand at room temperature for 4 hours, followed by TBST buffer solution. Rinse 3 times and rinse 3 times with water. Finally, the plastic slide is dried at 37 ° C. The plastic slide is developed with a laser scanner (Axon, USA). The development results are shown in Figure 2C Recover the green fluorescent spot that inhibits the binding of TNF — a / TNF — α R on the development of Figure 2C. The herbal grading solution corresponding to the green fluorescent spot contains an active ingredient capable of binding to TNF-a R. Analysis of the biological activity of the sample showing a positive green fluorescent signal confirms that the fractions collected above In order to inhibit the biological activity of TNF-α / but Ν XF — a R binding, the analytical method described in the document Mancini et al., Biochemical Pharmacology 58: 851-859, 1999, in which the known component is "suramin" (Surami η) was used as a positive control group, and two samples showing green fluorescence (Herbal C's grades 4 and 5) were tested, which corresponded to FIG. 2 Α herbal wafers Β 7 and Β 8 and Β 9 and B 1 0)). The test results are shown in FIG. 3. "Install (please read the precautions on the back before filling this page)

1-— 1 mmm— immm J ,· 1 1 n n mMMmm n ϋ 經濟部智慧財產局員工消費合作社印製 -Lr· in 1· txe _ 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公髮) -14 -1-— 1 mmm— immm J , · 1 1 nn mMMmm n 印 Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs-Lr · in 1 · txe _ This paper size applies to China National Standard (CNS) A4 (210 X 297 (Public) -14-

Claims (1)

1226927 :./v v, ,.…. A8 ,::¾ B8 C8 D8 六、申請專利範圍 附件: 第90 1 1 3 695號專利申請案 中文申請專利範圍修正本 (請先閱讀背面之注意事項再填寫本頁) 民國93年1 1月12日修正 1 · 一種用於篩選草藥中所欲活性成份之草藥晶片,其 包含塑膠載片、於該塑膠載片上之塗層及於該塗層上以微陣 列各別配置之方式結合至該塑膠載片上之草藥分級液或成份 ,其中該塗層包含偶合至該塑膠載片之多官能醛,該多官能 醛係偶合至能提供至少1個胺基之化合物,該能提供至少工 個胺基之化合物係結合至多官能環氧化物,該多官能環氧化 物包含至少1個能與該胺基偶合之環氧基和至少1個能與該 草藥分級液或成份偶合之環氧基。 2 ·如申請專利範圍第1項之草藥晶片,其中該草藥分 級液或成份係均一相或不均相。 3 ·如申請專利範圍第1項之草藥晶片,其中該草藥分 級液或成份之取得係藉由利用高效液相層析(Η P L C )分 級分離草藥之萃取液。 經濟部智慧財產局員工消費合作社印製 4 ·如申請專利範圍第1至3項中任一項之草藥晶片, 其中該草藥分級液或成份含有該草藥之二級代謝物。 5 .如申請專利範圍第1項之草藥晶片,其中該塑膠載 片之材料係聚碳酸酯,或由1或多種單體所製備之同聚物或 共聚物,該單體係選自乙烯,鹵乙烯,丙烯,鹵丙烯,丙燒 酸酯,甲基丙烯酸酯,丁二烯,丙烯腈,原冰片烯或苯乙烯 本紙張尺度適用中國國家榇準(CNS ) Α4規格 (210X297公釐) 1226927 Α8 Β8 C8 D8 六、申請專利範圍 6 ·如申請專利範圍第5項之草藥晶片,其中該塑膠載 片之材料係苯乙烯之聚合物。 (請先閱讀背面之注意事項再填寫本頁) 7 ·如申請專利範圍第1項之草藥晶片,其中該塑膠載 片含有2個凹槽。 8 ·如申請專利範圍第1項之草藥晶片,其中該多官能 醛係戊二醛。 9 ·如申請專利範圍第1項之草藥晶片,其中該提供胺 基之化合物係Ν Η 4〇Η。 1 0 ·如申請專利範圍第· 1項之草藥晶片,其中能與該 草藥分級液或成份偶合之環氧基係與自由羥基,氫硫基或胺 基反應。 1 1 ·如申請專利範圍第1項之草藥晶片,其中該多官 能環氧化物含有6至2 4個碳原子長之化學鏈。 1 2 · —種製造申請專利範圍第1項之草藥晶片之方 法,其包含下述步驟: 製備塑膠載片, 利用多官能醛及隨後浸沒於提供胺基之化合物溶液中 以先期處理該塑膠載片之表面, 經濟部智慧財產局員工消費合作社印製 利用多官能環氧化物塗覆該經先期處理之塑膠載片的 表面,及 _ 藉由使該多官能環氧化物與草藥分級液或成份偶合之方 式配置該草藥分級液或成份至該塑膠載片之塗層上。 1 3 ·如申請專利範圍第1 2項之方法,其中該塑膠載 片含有2個凹槽且該草藥分級液或成份係點配置或固定於該 本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐) 1226927 A8 B8 C8 D8 _ 六、申請專利範圍 凹槽之表面上。 1 4 ·如申請專利範圍第1 2或1 3項之方法,其中 該草藥分級液或成份係以微陣列之方式點配置或固定於欄 格面積上。 1 5 _如申請專利範圍第1 2或1 3項之方法,其中 該草藥分級液或成份係均一相或不均相。 1 6 ·如申請專利範圍第1 2項之方法,其中該多官能 醛係戊二醛。 1 7 ·如申請專利範圍第_1 2項之方法,其中該提供胺 基之化合物係N Η 4〇Η。 1 8 .如申請專利範圍第1 2項之方法,其中該多官能 環氧化物於其每1個終端含有至少1個環氧基。 1 9 · 一種利用申請專利範圍第1項之草藥晶片以篩 選草藥中所含有之活性成份之方法,其包含下述步驟: 載入含有標記探針之溶液至該草藥晶片上以進行雜交 反應,及 顯影並鑑別出能與該標記探針反應或結合之草藥分級 液或成份。 2 0 ·如申請專利範圍第1 9項之方法,其中該含有標 Ρϊ己ί木針之溶液係均一相或不均相。 2 1 ·如申請專利範圍第1 9項之方法.,其中該標記係 染料或放射性物質。 裝-- (請先閲·«背面之注意事項再填寫本頁) 、aT 經濟部智慧財產局員工消費合作社印製 本紙中國國家標準㈧叫以^^^^-—麓-^1226927: ./ vv,, ..... A8 :: ¾ B8 C8 D8 六 、 Applicable patent scope attachment: No. 90 1 1 3 695 Chinese patent application scope amendment (please read the precautions on the back before reading) (Fill in this page) Amended on January 12, 1993 1 · A herbal wafer for screening desired active ingredients in herbal medicine, comprising a plastic slide, a coating on the plastic slide, and a coating on the coating The microarrays are individually configured to be combined with the herbal grade liquid or ingredients on the plastic slide, wherein the coating comprises a polyfunctional aldehyde coupled to the plastic slide, and the polyfunctional aldehyde is coupled to provide at least one amine group. Compound, the compound capable of providing at least one amine group is bound to a polyfunctional epoxide, the polyfunctional epoxide contains at least 1 epoxy group capable of coupling with the amine group and at least 1 capable of grading with the herbal medicine Liquid or ingredient coupled epoxy. 2. If the herbal medicine chip of the scope of the patent application is No. 1, wherein the herbal grading solution or composition is homogeneous or heterogeneous. 3. If the herbal medicine wafer of item 1 of the patent application scope, wherein the herbal fraction or liquid is obtained by separating the herbal extract with high-performance liquid chromatography (ΗPLC). Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs 4 · If any of the herbal medicine wafers in any of claims 1 to 3 of the patent application scope, wherein the herbal grade liquid or ingredient contains the secondary metabolite of the herbal medicine. 5. If the herbal wafer of item 1 of the patent application scope, wherein the material of the plastic slide is polycarbonate, or a homopolymer or copolymer prepared from one or more monomers, the single system is selected from ethylene, Vinyl halide, propylene, halopropylene, propionate, methacrylate, butadiene, acrylonitrile, orthobornene or styrene. The paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 1226927 Α8 Β8 C8 D8 6. Scope of patent application 6 · For example, the herbal wafer of the scope of patent application No. 5 in which the material of the plastic slide is a polymer of styrene. (Please read the precautions on the back before filling out this page) 7 · If the herbal medicine wafer in the scope of patent application item 1, the plastic slide contains 2 grooves. 8. The herbal medicine wafer according to item 1 of the application, wherein the polyfunctional aldehyde is glutaraldehyde. 9) The herbal medicine wafer according to item 1 of the patent application scope, wherein the compound providing an amine group is NΗ40Η. 10 • The herbal medicine wafer according to item 1 of the scope of patent application, wherein the epoxy group capable of coupling with the herbal grading solution or ingredients reacts with a free hydroxyl group, a hydrogen thio group or an amine group. 1 1 · The herbal wafer according to item 1 of the patent application, wherein the multifunctional epoxide contains a chemical chain of 6 to 24 carbon atoms. 1 2 · A method for manufacturing an herbal wafer of the scope of patent application, which includes the following steps: preparing a plastic slide, using a polyfunctional aldehyde and subsequently immersing in a solution of an amine-based compound to pre-treat the plastic slide The surface of the film is printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, and the surface of the pre-treated plastic slide is coated with a polyfunctional epoxide, and by using the polyfunctional epoxide with a herbal grade solution or ingredients The coupling method is to dispose the herbal grade liquid or ingredients on the coating of the plastic slide. 1 3 · The method according to item 12 of the scope of patent application, wherein the plastic slide contains 2 grooves, and the herbal grading solution or ingredients are arranged or fixed on the paper. The Chinese national standard (CNS) A4 specification is applicable. (210 X 297 mm) 1226927 A8 B8 C8 D8 _ 6. The surface of the groove in the patent scope. 14 · The method according to item 12 or 13 of the scope of application for a patent, wherein the herbal grading solution or component is arranged or fixed on the grid area in a microarray manner. 1 5 _ The method according to item 12 or 13 of the scope of patent application, wherein the herbal grading solution or composition is homogeneous or heterogeneous. 16. The method according to item 12 of the scope of patent application, wherein the polyfunctional aldehyde is glutaraldehyde. 17. The method according to item 12 of the scope of patent application, wherein the compound providing an amine group is NΗ40Η. 18. The method according to item 12 of the scope of patent application, wherein the polyfunctional epoxide contains at least one epoxy group at each terminal thereof. 19 · A method for screening active ingredients contained in herbal medicines by using the herbal medicine wafers in the scope of patent application, including the following steps: loading a solution containing a labeled probe onto the herbal wafers to perform a hybridization reaction, And develop and identify the herbal fraction or component that can react or bind with the labeled probe. 20 · The method according to item 19 of the scope of application for a patent, wherein the solution containing a standard wooden needle is homogeneous or heterogeneous. 2 1 · The method according to item 19 of the scope of patent application, wherein the mark is a dye or a radioactive substance. Packing-(Please read the «Notes on the back before filling out this page), printed by the aT Consumer Intellectual Property Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs This paper is called ^^^^ -— 陆-^
TW90113695A 2001-06-06 2001-06-06 Herbal chip TWI226927B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW90113695A TWI226927B (en) 2001-06-06 2001-06-06 Herbal chip

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW90113695A TWI226927B (en) 2001-06-06 2001-06-06 Herbal chip

Publications (1)

Publication Number Publication Date
TWI226927B true TWI226927B (en) 2005-01-21

Family

ID=35654696

Family Applications (1)

Application Number Title Priority Date Filing Date
TW90113695A TWI226927B (en) 2001-06-06 2001-06-06 Herbal chip

Country Status (1)

Country Link
TW (1) TWI226927B (en)

Similar Documents

Publication Publication Date Title
Sun et al. Recent advances in microarray technologies for proteomics
Weinberger et al. Recent trends in protein biochip technology
Cretich et al. Protein and peptide arrays: recent trends and new directions
Templin et al. Protein microarrays: promising tools for proteomic research
Seong et al. Current status of protein chip development in terms of fabrication and application
Templin et al. Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?
EP1728079A1 (en) Methods and biochips for detecting small molecule compounds
Albala Array-based proteomics: the latest chip challenge
JP2004536290A (en) Methods for producing stable and reproducible antibody arrays
US6534270B2 (en) Biochip and method for fabricating the same
EP0818467A2 (en) Aligned peptide array and a rational and rapid method for the detection of a binding or interaction site of a protein by using the same
Du et al. Development of miniaturized competitive immunoassays on a protein chip as a screening tool for drugs
JP3661942B2 (en) Herbal chips
TWI226927B (en) Herbal chip
Marquette et al. Latex bead immobilisation in PDMS matrix for the detection of p53 gene point mutation and anti-HIV-1 capsid protein antibodies
EP1265070B1 (en) Chip exposing plant extracts on its surface
Venton et al. Screening combinatorial libraries
Matson Applying genomic and proteomic microarray technology in drug discovery
Zong et al. Forward-phase and reverse-phase protein microarray
O'Connor et al. Protein chips and microarrays
US20100267581A1 (en) High throughput integrated microfluidic system and device
CN1164945C (en) Chinese-herbal medicine chip
Souplet et al. In situ ligation between peptides and silica nanoparticles for making peptide microarrays on polycarbonate
Ito Microarray Chips (in Vitro Diagnosis)
JP2004198140A (en) Biomolecule detection method and device

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees